PATENT CLAIM ANALYSIS

Application Number: 15989414
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-02
Patent Classification: ["514", "300000"]

Abstract:
The present disclosure relates to solid forms of N-{[2′-(2,6-difluoro-3,5-dimethoxyphenyl)-3′-oxo-2′,3′-dihydro-1′H-spiro[cyclopropane-1,4′-[2,7]naphthyridin]-6′-yl]methyl}acrylamide, methods of preparation thereof, and intermediates in the preparation thereof, which are useful in the treatment of the FGFR-associated or mediated diseases such as cancer.

Claim (Index 3):
The solid form of  claim 2  having Form I.

Metadata:
- Claim Count in Document: 146.0
- Percentile: 93.0
- Lexical Diversity: 1.29545
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15626539', '15856845', '14945147', '13962745', '15502639']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8099854683142064
- 35 USC 102 Novelty (BERT): 0.5175777301253506
- Combined Prediction Score: 0.7807446944953208
- Mean Citation Score: 245.044878
- Max Citation Score: 259.8712
- Similarity Product: 160.36661055631637

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test